Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.871 |
High Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8594 |
High Similarity |
NPD3027 |
Phase 3 |
0.8559 |
High Similarity |
NPD228 |
Approved |
0.8231 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8154 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8154 |
Intermediate Similarity |
NPD9494 |
Approved |
0.8145 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.8125 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8125 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.812 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.812 |
Intermediate Similarity |
NPD1613 |
Approved |
0.806 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8047 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7972 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7943 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7877 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7838 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7829 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7823 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7817 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7708 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7623 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7597 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7591 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7586 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7584 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7563 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7552 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.754 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7519 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7482 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7464 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7464 |
Intermediate Similarity |
NPD943 |
Approved |
0.7448 |
Intermediate Similarity |
NPD5297 |
Approved |
0.7424 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7415 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7394 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7319 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7319 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7303 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7293 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7278 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7266 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7258 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7254 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7222 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7213 |
Intermediate Similarity |
NPD846 |
Approved |
0.7213 |
Intermediate Similarity |
NPD940 |
Approved |
0.7213 |
Intermediate Similarity |
NPD291 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.72 |
Intermediate Similarity |
NPD290 |
Approved |
0.7197 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7194 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7185 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7123 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7121 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7092 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7092 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7071 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD9094 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD37 |
Approved |
0.7054 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7047 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7039 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7037 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7031 |
Intermediate Similarity |
NPD9280 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7023 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7013 |
Intermediate Similarity |
NPD4585 |
Approved |
0.7007 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6987 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6974 |
Remote Similarity |
NPD824 |
Approved |
0.6972 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6966 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6963 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6959 |
Remote Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.695 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD919 |
Approved |
0.6939 |
Remote Similarity |
NPD3060 |
Approved |
0.6933 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6929 |
Remote Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD4966 |
Approved |
0.6923 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6923 |
Remote Similarity |
NPD4965 |
Approved |
0.6923 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6914 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6913 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6903 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD5494 |
Approved |
0.6892 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6889 |
Remote Similarity |
NPD1778 |
Approved |
0.6887 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD4005 |
Discontinued |
0.6861 |
Remote Similarity |
NPD9717 |
Approved |
0.6859 |
Remote Similarity |
NPD5353 |
Approved |
0.6855 |
Remote Similarity |
NPD1247 |
Approved |
0.6855 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6852 |
Remote Similarity |
NPD7228 |
Approved |
0.685 |
Remote Similarity |
NPD968 |
Approved |
0.6849 |
Remote Similarity |
NPD2796 |
Approved |
0.6849 |
Remote Similarity |
NPD6099 |
Approved |
0.6849 |
Remote Similarity |
NPD6100 |
Approved |
0.6842 |
Remote Similarity |
NPD9493 |
Approved |
0.6824 |
Remote Similarity |
NPD4237 |
Approved |
0.6824 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6822 |
Remote Similarity |
NPD4750 |
Phase 3 |
0.6821 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6815 |
Remote Similarity |
NPD5691 |
Approved |
0.6812 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.681 |
Remote Similarity |
NPD111 |
Approved |
0.6806 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6803 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6797 |
Remote Similarity |
NPD3686 |
Approved |
0.6797 |
Remote Similarity |
NPD3687 |
Approved |
0.6795 |
Remote Similarity |
NPD7819 |
Suspended |
0.6794 |
Remote Similarity |
NPD9379 |
Approved |
0.6794 |
Remote Similarity |
NPD9377 |
Approved |
0.6783 |
Remote Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.6781 |
Remote Similarity |
NPD3748 |
Approved |
0.6779 |
Remote Similarity |
NPD8166 |
Discontinued |
0.677 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.677 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6767 |
Remote Similarity |
NPD6671 |
Approved |
0.6765 |
Remote Similarity |
NPD9381 |
Approved |
0.6765 |
Remote Similarity |
NPD9384 |
Approved |
0.6763 |
Remote Similarity |
NPD3225 |
Approved |
0.6761 |
Remote Similarity |
NPD7095 |
Approved |
0.6759 |
Remote Similarity |
NPD2492 |
Phase 1 |
0.6757 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6753 |
Remote Similarity |
NPD3866 |
Clinical (unspecified phase) |
0.6752 |
Remote Similarity |
NPD5402 |
Approved |
0.6747 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6739 |
Remote Similarity |
NPD1608 |
Approved |
0.6738 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6732 |
Remote Similarity |
NPD5403 |
Approved |
0.6731 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6726 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6723 |
Remote Similarity |
NPD9295 |
Approved |
0.6714 |
Remote Similarity |
NPD1203 |
Approved |
0.6713 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6713 |
Remote Similarity |
NPD411 |
Approved |
0.6711 |
Remote Similarity |
NPD1424 |
Approved |
0.6711 |
Remote Similarity |
NPD2533 |
Approved |
0.6711 |
Remote Similarity |
NPD4123 |
Phase 3 |
0.6711 |
Remote Similarity |
NPD2534 |
Approved |
0.6711 |
Remote Similarity |
NPD2532 |
Approved |
0.6711 |
Remote Similarity |
NPD5401 |
Approved |
0.6692 |
Remote Similarity |
NPD9299 |
Approved |
0.6692 |
Remote Similarity |
NPD556 |
Approved |
0.6691 |
Remote Similarity |
NPD1651 |
Approved |
0.6691 |
Remote Similarity |
NPD9622 |
Approved |
0.669 |
Remote Similarity |
NPD1933 |
Approved |
0.6687 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6687 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6667 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.6667
|
Remote Similarity |
NPD1408 |
Clinical (unspecified phase) |